Evidence map›Paper›PMID 42305534›Full record

ArticleFrontiers in immunology2026

A feedback loop sustaining neutrophil extracellular trap formation involves S100 proteins, histones, TLR2 and RAGE, and is restrained by albumin.

Vanessa de Carvalho Oliveira, Matthew Mazur, Patrick P McDonald

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vanessa de Carvalho OliveiraPulmonary Division, Medicine Faculty, Université de Sherbrooke, Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke (CRCHUS), Sherbrooke, QC, Canada.
Matthew MazurDepartment of Research, Insmed Incorporated, Bridgewater, NJ, United States.
Patrick P McDonaldPulmonary Division, Medicine Faculty, Université de Sherbrooke, Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke (CRCHUS), Sherbrooke, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil extracellular trap (NET) generation must be tightly controlled as this essential antimicrobial response can also cause tissue damage and contribute to various pathologies. We previously described that neutrophils undergoing NET formation release endogenous mediators that feedback on the cells via the RAGE receptor to drive the response. We now identify S100 proteins and histones as prominent endogenous NET inducers. Mass spectrometry analyses of culture supernatant from NETing neutrophils revealed the presence of seven species of S100 proteins and ten histone variants, all of which could bind to RAGE. In addition, endogenous NET inducers were found to act via TLR2 since antagonism of the receptor for up to 3 h post-stimulation hindered NET formation elicited by various classes of physiological stimuli. By comparison, antagonism of TLR4 did not inhibit NET generation. Conversely, we show that serum or equivalent albumin concentrations restrain NET formation by sequestering endogenous NET inducers. Serum depleted of albumin indeed loses its ability to prevent NET formation; likewise, the belated addition of HSA to culture medium blocks NET generation. Prior exposure to serum or albumin renders endogenous NET inducers unable to trigger the response; mass spectrometry analyses confirmed that albumin captures S100 proteins. Collectively, our data unveil a feedback loop of NET formation involving endogenous S100 proteins and histones, acting through RAGE and/or TLR2, that can be physiologically counteracted by albumin.

Indexed as

Extracellular TrapsHistonesNeutrophilsReceptor for Advanced Glycation End ProductsS100 ProteinsToll-Like Receptor 2Feedback, PhysiologicalHumansHistonesReceptor for Advanced Glycation End ProductsS100 ProteinsTLR2 protein, humanToll-Like Receptor 2DAMPsendogenous factorshistoneshuman serum albuminneutrophil extracellular trapsRAGES100 proteinsTLR2

Identifiers

PMID42305534
PMCPMC13265349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.